<< Click to Display Table of Contents >>

Navigation:  Filling Scripts >


Using Medi-Span, ProPharm One+ can prevent drug interactions by alerting you to possible problems as you fill scripts. If a drug is being dispensed that will cause interactions or allergic reactions for the patient, a warning message will display in the Script Filling screen.


After you have entered the drug information and added quantities and directions, ProPharm will screen the script for possible issues.



What Information is Screened?

What Causes Different Screening Alerts?

Where Can I Find More Information?

Screening Types



What Information is Screened?

ProPharm One+ screens drug information based on drug data received from Medi-Span. This information is compared with the patient's profile to determine if any interactions or allergic reactions are likely to occur. Drug screening takes into account information such as:


Current medications


Existing medical conditions



What Causes Different Screening Alerts?

When a script is screened, the results will appear near the bottom of the filling screen in the DUR section. Here are some of the results that may be shown:


Minor: If a minor allergic reaction, drug interaction, or contraindication may be caused by the dispensed drug, you will receive the "Minor" screening alert.


Moderate: If a more serious problem (allergic reaction, contraindication, etc.) may be caused by the dispensed drug, you will receive the "Moderate" screening alert. This message is a warning that adverse effects are possible if the selected drug is dispensed to the patient.


Major: If a severe allergic reaction, drug interaction, or contraindication may be caused by the drug that is being dispensed, you will receive the "Major" screening alert. This message is a warning that dispensing the selected drug to the patient could cause serious health problems.


Medi-Span has the following warning levels, in order of urgency:








The level of interaction that will cause a screening alert can be configured from the Medi-Span Options screen.



Where Can I Find More Information?

To view detailed information about screening results, click on the DUR Information button. This will open the DUR Results window and you can see details about the drug screening. If there are any Adverse Drug Effects, Precautions, etc., then details of those alerts will be shown here. You can also print a DUR Report from this window by clicking on the Print Results button.


If there is additional screening information to view beyond what is shown in the four DUR fields of the Script Filling screen, a More indicator will appear in the DUR section. This alerts users to the fact that there is additional information to be viewed by clicking on the DUR Information button.


For a further explanation of how the script was screened, you can click on the Explain Results button within the DUR Results window. This will open a new page, showing details about how the drug in this script was screened. It will also show information about existing drugs on the patient's profile that the current drug is being screened against. If any items were not able to be screened, a warning message will appear. This screen also contains a "Screening Parameters" section, which shows some of the logic behind screening alerts.



Screening Types

There are different types of screening which take place during the script filling process. Below is a description of each screening type.


Adverse Drug Effects (ADE) Screening:

"Adverse Drug Effects" are unintended and undesired effects that are caused by the use of a medication. This screening does not determine whether the unintended results are positive or negative, but merely shows that the effects are not the intended, desired outcome of taking the drug. This screening examines information from the patient's drug records and medical conditions.


Compliance Screening:

"Early and Late Compliance" screening determines if scripts are being refilled at the appropriate time. If a script is being refilled too soon or if it is overdue, a Compliance screening error will be triggered.


Dose Check (DC) Screening:

This screening will alert you to drug doses that are outside the standard dosing range. You will be alerted if the selected dose is either an overdose or a sub-therapeutic dose.


Drug Food Alcohol (DFA) Screening:

Drug-food and drug-alcohol interactions refer to instances where a medication, when combined with food or alcohol, produces a different effect than when it is administered alone. This screening will alert users to any known interactions between the selected drug and alcohol or foods.


Drug Interaction (DI) Screening:

Drug-to-drug interactions occur when one drug has a different effect when it is combined with another drug than it would on its own. Information for this screening is taken from the patient's drug record.


Duplicate Therapy (DT) Screening:

Because a particular drug may be used for multiple therapeutic purposes, drugs are assigned a duplication class for each appropriate therapeutic class. DT Screening will alert you to possible cases of duplicate therapy.


Contraindication Screening:

"Contraindication" alerts indicate medical conditions which may either (1) adversely affect the action of specific drugs or (2) become worse due to the administration of particular drugs. Occurrences of this alert may range from unconfirmed, potential problems to definite contraindications. Factors which may cause contraindication alerts are drawn from the patient's drug records and medical condition information.


Prior Adverse Reactions (PAR) Screening:

This screening reviews a set of drugs and allergies to determine if any of the selected drugs might cause an allergic reaction in the patient. Drug and allergy information is drawn from the patient's profile. This screening identifies problems regarding the patient's current or prospective drug regimen.